Deep knowledge on
small-molecule drugs and
the 100,000 global patents
covering them

Flexible Flat-Rate Plans

Flat-rate pricing for predictable budgeting

Short-term plans for project- or client-based billing

► Plans and Pricing

How are People Using DrugPatentWatch?

DrugPatentWatch Ultimate Plan Preview

Details for NDA: 022249

« Back to Dashboard
NDA 022249 describes TREANDA, which is a drug marketed by Cephalon and is included in one NDA. It is available from one supplier. There are eight patents protecting this drug and two Paragraph IV challenges. Additional details are available on the TREANDA profile page.

The generic ingredient in TREANDA is bendamustine hydrochloride. There are twenty-two drug master file entries for this compound. One supplier is listed for this compound. There are three tentative approvals for this compound. Additional details are available on the bendamustine hydrochloride profile page.

Summary for NDA: 022249

bendamustine hydrochloride

Pharmacology for NDA: 022249

Mechanism of ActionAlkylating Activity

Suppliers and Packaging for NDA: 022249

Tradename Generic Name Dosage NDA Supplier National Drug Code Package Code Package
bendamustine hydrochloride
POWDER;IV (INFUSION) 022249 Cephalon, Incorporated 63459-390 63459-390-08 1 VIAL, SINGLE-DOSE in 1 CARTON (63459-390-08) > 5 mL in 1 VIAL, SINGLE-DOSE
bendamustine hydrochloride
POWDER;IV (INFUSION) 022249 Cephalon, Incorporated 63459-391 63459-391-20 1 VIAL, SINGLE-DOSE in 1 CARTON (63459-391-20) > 20 mL in 1 VIAL, SINGLE-DOSE

Summary for product number 001

Active Rx/OTC/Discontinued:RXDosage:POWDER;IV (INFUSION)Strength100MG/VIAL
Approval Date:Mar 20, 2008TE:RLD:Yes
Patent:8,436,190*PEDPatent Expiration:Apr 26, 2031Product Flag?Substance Flag?Delist Request?Y
Patent:8,445,524*PEDPatent Expiration:Sep 26, 2029Product Flag?Substance Flag?Delist Request?Y
Patent:8,609,863*PEDPatent Expiration:Jul 12, 2026Product Flag?Substance Flag?Delist Request?Y

Complete Access Available with Subscription
« Back to Dashboard

For more information try a trial or see the database preview and plan comparison

Drugs may be covered by multiple patents or regulatory protections. All trademarks and applicant names are the property of their respective owners or licensors.

Although great care is taken in the proper and correct provision of this service, thinkBiotech LLC does not accept any responsibility for possible consequences of errors or omissions in the provided information. There is no warranty that the information contained herein is error free. Users of this service are advised to seek professional advice and independent confirmation before considering acting on any of the provided information. thinkBiotech LLC reserves the right to amend, extend or withdraw any part or all of the offered service without notice.

Copyright 2002-2016 thinkBiotech LLC
ISSN: 2162-2639

Preferred citation:

Friedman, Y. Location of pharmaceutical innovation: 2000–2009 Nature Reviews Drug Discovery 9, 835–836 (2010).

Connect with Social Media:

Follow DrugPatentWatch on Twitter
Connect with DrugPatentWatch on Linkedin
Drug Patents on LinkedIn